Expression of concern
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Paper Information
Record ID:
35388
Publication Date:
April 22, 2021
Retraction Date:
February 07, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Front-Line Covid-19 Critical Care Alliance, Madison, WI
- Memphis VA Medical Center—University of Tennessee Health Science Center, Pulmonary, Critical Care, and Research Services, Memphis, TN
- University of Texas Health Science Center, Critical Care Service, Houston, TX
- Department of Medicine, Hackensack School of Medicine, Seton Hall, NJ
- Eastern Virginia Medical School, Division of Pulmonary and Critical Care, Norfolk, VA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1097/MJT.0000000000001481Citations (163)
163
Total Citations105
Post-Retraction(64.4%)
58
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
8
Within 30 days
73
Within 1 year
9
After 2+ years
1232
Days since retraction (latest)
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
Steven Lim, Chee Peng Hor, Kim Heng Tay et al. (100 authors)
JAMA Internal Medicine
Open Access
Published: Feb 2022
91 citations
91 citations
11 days after retraction
Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic
Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis et al. (11 authors)
Medicina
Open Access
Published: Feb 2022
6 citations
6 citations
10 days after retraction
Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection
Alberto Boretti
Journal of Trace Elements in Medicine and Biology
Open Access
Published: Feb 2022
10 citations
10 citations
10 days after retraction
Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications
Albertus A. Meyer, E.H. Mathews, Andries Gous et al. (4 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Feb 2022
1 citation
1 citation
9 days after retraction
Unresolved COVID Controversies: ‘Normal science’ and potential non-scientific influences
Carlos F. Cáceres
Global Public Health
Published: Feb 2022
11 citations
11 citations
8 days after retraction
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
Farshad M. Shirazi, Roya Mirzaei, Samaneh Nakhaee et al. (6 authors)
European journal of medical research
Open Access
Published: Feb 2022
17 citations
17 citations
2 days before retraction
Ivermectin in COVID-19 Management: What is the Current Evidence?
Madhavi Eerike, Gerard Marshall Raj, Rekha Priyadarshini et al. (6 authors)
Infectious Disorders - Drug Targets
Published: Jan 2022
1 citation
1 citation
19 days before retraction
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
Andrew Hill, Manya Mirchandani, Victoria Pilkington
Open Forum Infectious Diseases
Open Access
Published: Jan 2022
52 citations
52 citations
21 days before retraction
Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review
Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic et al. (14 authors)
Therapeutic Advances in Vaccines and Immunotherapy
Open Access
Published: Jan 2022
13 citations
13 citations
37 days before retraction
Why are children and many adults not affected by COVID-19? Role of the host immune response
Hélène Banoun
Infectious Diseases Research
Open Access
Published: Jan 2022
5 citations
5 citations
37 days before retraction
The Effects Of The Covid-19 Pandemic And Covid-19 Measures On University Students Related To Levels Of Anxiety And Depression
Esma Deniz Barc
Journal of Biomedical and Allied Research
Open Access
Published: Jan 2022
1 citation
1 citation
37 days before retraction
Drug safety of frequently used drugs and substances for self-medication in COVID-19
Daniela Baracaldo-Santamaría, Santiago Pabón-Londoño, Luis Carlos Rojas-Rodríguez
Therapeutic Advances in Drug Safety
Open Access
Published: Jan 2022
24 citations
24 citations
37 days before retraction
Covid-19 pandemic: What is the truth?
Russell L. Blaylock
Surgical Neurology International
Open Access
Published: Dec 2021
6 citations
6 citations
61 days before retraction
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19
Steven G. Rothrock, Kurt Weber, Philip Giordano et al. (4 authors)
American Journal of Therapeutics
Open Access
Published: Dec 2021
11 citations
11 citations
62 days before retraction
The military as a neglected pathogen transmitter, from the nineteenth century to COVID-19: a systematic review
Claudia Chaufan, Ilinca A. Dutescu, Hanah Fekre et al. (5 authors)
Global Health Research and Policy
Open Access
Published: Dec 2021
6 citations
6 citations
68 days before retraction
Ivermectin
Patricia Anne O’Malley
Clinical Nurse Specialist
Open Access
Published: Nov 2021
1 citation
1 citation
75 days before retraction
Effectiveness and safety of Ivermectin in COVID‐19 patients: A prospective study at a safety‐net hospital
Muhammet Özer, Suleyman Yasin Goksu, Reena Conception et al. (12 authors)
Journal of Medical Virology
Open Access
Published: Nov 2021
18 citations
18 citations
76 days before retraction
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Nov 2021
145 citations
145 citations
81 days before retraction
Steroids Induced Black Fungus Infection in India During the May 2021 COVID-19 Outbreak
Alberto Boretti
Indian Journal of Otolaryngology and Head & Neck Surgery
Open Access
Published: Nov 2021
4 citations
4 citations
84 days before retraction
Identification and Development of Therapeutics for COVID-19
Halie M. Rando, Nils Wellhausen, Soumita Ghosh et al. (23 authors)
mSystems
Open Access
Published: Nov 2021
19 citations
19 citations
97 days before retraction
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19: Erratum
Unknown Authors
American Journal of Therapeutics
Open Access
Published: Nov 2021
98 days before retraction
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?
Anatoly Mayburd
Expert Review of Anti-infective Therapy
Published: Oct 2021
100 days before retraction
Reposicionamiento de ivermectina frente a COVID-19: evidencias científicas que avalan su potencial preventivo y terapéutico
A. Lifschitz, Luis E. Álvarez, Laura Ceballos et al. (4 authors)
FAVE Sección Ciencias Veterinarias
Open Access
Published: Oct 2021
101 days before retraction
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Zheng Yao Low, Ashley Jia Wen Yip, Sunil K. Lal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Open Access
Published: Oct 2021
42 citations
42 citations
108 days before retraction
Rapid Response: Ivermectin in Covid-19
Andrew Bryant, Theresa A Lawrie, Edmund J. Fordham et al. (4 authors)
Unknown Journal
Open Access
Published: Oct 2021
117 days before retraction
The military as a neglected pathogen transmitter, from the 19th century to COVID-19: A systematic review
Claudia Chaufan, Ilinca A. Dutescu, Hanah Fekre et al. (5 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2021
118 days before retraction
The uses and abuses of systematic reviews
Edmund J. Fordham, Theresa A Lawrie, Katherine S. MacGilchrist et al. (4 authors)
Unknown Journal
Published: Oct 2021
2 citations
2 citations
123 days before retraction
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics
Sriram Kumar, Duygu Merve Çalışkan, Josua Janowski et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Oct 2021
25 citations
25 citations
129 days before retraction
Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects
Yuri Lazebnik
Oncotarget
Open Access
Published: Sep 2021
15 citations
15 citations
130 days before retraction
Ivermectin Research Should Not Be Used to Promote Vaccine Opposition
Peter Manu
American Journal of Therapeutics
Open Access
Published: Sep 2021
1 citation
1 citation
133 days before retraction
Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs
Addie B. Spier, Colin E. Evans
Frontiers in Cardiovascular Medicine
Open Access
Published: Sep 2021
1 citation
1 citation
139 days before retraction
Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis
Jiawen Deng, Fangwen Zhou, Saif Ali et al. (7 authors)
QJM
Open Access
Published: Sep 2021
34 citations
34 citations
139 days before retraction
Use and abuses of systematic reviews
Edmund J. Fordham, Theresa A Lawrie, Katherine S. MacGilchrist et al. (4 authors)
Unknown Journal
Published: Sep 2021
157 days before retraction
Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection
Annelies Boven, Chris Kenyon, Robert Colebunders
Open Forum Infectious Diseases
Open Access
Published: Sep 2021
158 days before retraction
Ivermectin, A Reanalysis of the Data
Paul E. Marik, Pierre Kory
American Journal of Therapeutics
Open Access
Published: Sep 2021
9 citations
9 citations
159 days before retraction
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study
José Morgenstern, José N Redondo, A Landaluce Olavarria et al. (16 authors)
Cureus
Open Access
Published: Aug 2021
13 citations
13 citations
165 days before retraction
Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
Deepak K. Tempe
The Lancet Infectious Diseases
Open Access
Published: Aug 2021
167 days before retraction
Meta-analytic magic, ivermectin, and socially responsible reporting
Andrew Parrish, Marc Blockman, Karen Cohen et al. (11 authors)
South African Medical Journal
Open Access
Published: Aug 2021
6 citations
6 citations
174 days before retraction
Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina
Rossana Elena Chahla, Luis Medina Ruiz, Eugenia Silvana Ortega et al. (11 authors)
American Journal of Therapeutics
Open Access
Published: Aug 2021
29 citations
29 citations
175 days before retraction
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
Raquel Cobos‐Campos, Antxon Apiñaniz, Naiara Parraza et al. (6 authors)
Current Research in Translational Medicine
Open Access
Published: Aug 2021
10 citations
10 citations
180 days before retraction
A TALE OF TWO SCIENTIFIC PARADIGMS: CONFLICTING SCIENTIFIC OPINIONS ON WHAT “FOLLOWING THE SCIENCE” MEANS FOR SARS-COV-2 AND THE COVID-19 PANDEMIC
Gerry A. Quinn, Ronan Connolly, Coilín ÓhAiseadha et al. (4 authors)
Unknown Journal
Open Access
Published: Aug 2021
5 citations
5 citations
180 days before retraction
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
Alessandro D. Santin, David Scheim, Peter A. McCullough et al. (5 authors)
New Microbes and New Infections
Open Access
Published: Aug 2021
26 citations
26 citations
188 days before retraction
Ivermectin for preventing and treating COVID-19
Maria Popp, Miriam Stegemann, Maria‐Inti Metzendorf et al. (8 authors)
Cochrane library
Open Access
Published: Jul 2021
90 citations
90 citations
194 days before retraction
Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications
Giovanny Carvalho dos Santos, Lucas Michelão Martins, Bruna Andressa Bregadiolli et al. (6 authors)
Journal of Heterocyclic Chemistry
Published: Jul 2021
36 citations
36 citations
196 days before retraction
The economic impact of lockdowns: A theoretical assessment
Gabriele Camera, Alessandro Gioffré
Journal of Mathematical Economics
Open Access
Published: Jul 2021
12 citations
12 citations
204 days before retraction
Ivermectin as a multifaceted drug in COVID-19: Current insights
Ankur Khandelwal, Gyaninder Pal Singh, Shaista Jamil
Medical Journal Armed Forces India
Open Access
Published: Jul 2021
3 citations
3 citations
221 days before retraction
Inaccurate Real-World Data Does Not Provide Real-World Answers
Gabriela Buffet, Raúl Andrés Mendoza-Sassi, M. Fysekidis
American Journal of Therapeutics
Open Access
Published: Jun 2021
1 citation
1 citation
223 days before retraction
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous et al. (15 authors)
EMBO Molecular Medicine
Open Access
Published: Jun 2021
49 citations
49 citations
227 days before retraction
Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yuani M. Roman, Paula Alejandra Burela, Vinay Pasupuleti et al. (6 authors)
Clinical Infectious Diseases
Open Access
Published: Jun 2021
109 citations
109 citations
227 days before retraction
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Andrew Bryant, Theresa A Lawrie, Therese Dowswell et al. (7 authors)
American Journal of Therapeutics
Open Access
Published: Jun 2021
233 citations
233 citations
233 days before retraction
Quick Stats
Total Citations:
163
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025